ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
12.53
-0.05 (-0.40%)
At close: Apr 1, 2025, 4:00 PM
12.61
+0.08 (0.64%)
After-hours: Apr 1, 2025, 7:02 PM EDT

ARS Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
8-54.37-34.68-20.24-1.07
Depreciation & Amortization
0.080.070.030.210.01
Other Amortization
----0
Asset Writedown & Restructuring Costs
--1.06--
Loss (Gain) From Sale of Investments
-7.25-6.850.29--
Stock-Based Compensation
14.539.245.842.833.54
Other Operating Activities
--0.14-00.12
Change in Accounts Receivable
-8.18----
Change in Inventory
-5.95----
Change in Accounts Payable
16.43-2.78-10.290.971.19
Change in Unearned Revenue
2.09-3.14-1.32-2.516.96
Change in Other Net Operating Assets
-6.21-1.45-1.151.18-1.69
Operating Cash Flow
13.55-59.27-40.08-17.569.07
Capital Expenditures
-0.56-0.18-0.2-0.06-
Sale (Purchase) of Intangibles
-7.5----
Investment in Securities
-98.04-87.01---
Investing Cash Flow
-106.1-87.18-0.2-0.06-
Long-Term Debt Issued
69.38---5
Long-Term Debt Repaid
---8.68-1.82-
Net Debt Issued (Repaid)
69.38--8.68-1.825
Issuance of Common Stock
3.026.90.570.170.1
Other Financing Activities
--198.84--
Financing Cash Flow
72.46.9190.7353.165.1
Net Cash Flow
-20.15-139.55150.4635.5414.17
Free Cash Flow
12.99-59.44-40.28-17.629.07
Free Cash Flow Margin
14.57%-198136.67%-3060.56%-319.94%50.86%
Free Cash Flow Per Share
0.13-0.62-1.01-0.610.45
Cash Interest Paid
--0.370.580.33
Levered Free Cash Flow
8.96-36.17-17.86-9.57-
Unlevered Free Cash Flow
8.96-36.17-17.86-9.07-
Change in Net Working Capital
-4.343.112-0.11-
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q